Acetyl-CoA Carboxylase Inhibition Reverses NAFLD and Hepatic Insulin Resistance but Promotes Hypertriglyceridemia in Rodents-Reference-Cited by-同舟云学术

Acetyl-CoA Carboxylase Inhibition Reverses NAFLD and Hepatic Insulin Resistance but Promotes Hypertriglyceridemia in Rodents

Published:2018-11-29 Issue:6 Volume:68 Page:2197-2211
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Goedeke Leigh¹,Bates Jamie²,Vatner Daniel F.¹,Perry Rachel J.¹,Wang Ting²,Ramirez Ricardo²,Li Li²,Ellis Matthew W.³,Zhang Dongyan¹,Wong Kari E.⁴,Beysen Carine⁵,Cline Gary W.¹,Ray Adrian S.²,Shulman Gerald I.¹³⁶

Affiliation:

1. Department of Internal Medicine; Yale University School of Medicine; New Haven CT

2. Gilead Sciences Inc.; Foster City CA

3. Department of Cellular and Molecular Physiology; Yale University School of Medicine; New Haven CT

4. Metabolon Inc.; Morrisville NC

5. Independent Researcher; San Mateo CA

6. Howard Hughes Medical Institute; Yale University School of Medicine; New Haven CT

Funder

National Institutes of Health

National Institute of Diabetes and Digestive and Kidney Diseases

Gilead Sciences

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.30097/fullpdf

Reference41 articles.

1. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity;Browning;Hepatology,2004

2. Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease;Shulman;N Engl J Med,2014

3. Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications;Fabbrini;Hepatology,2010

4. Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes;Birkenfeld;Hepatology,2014

5. The problem of establishing relationships between hepatic steatosis and hepatic insulin resistance;Farese;Cell Metab,2012

Cited by 167 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diisoprenyl-cyclohexene-type meroterpenoids from a mangrove endophytic fungus Aspergillus sp. GXNU-Y65 and their anti-nonalcoholic steatohepatitis activity in AML12 cells;Phytochemistry;2024-02

2. Pharmacologic inhibition of lipogenesis for the treatment of NAFLD;Journal of Hepatology;2024-02

3. Advancements in metabolic‐associated steatotic liver disease research: Diagnostics, small molecule developments, and future directions;Hepatology Research;2024-01-22

4. Altered Lipid Metabolism as a Predisposing Factor for Liver Metastasis in MASLD;Molecules and Cells;2024-01

5. Qing-Zhi-Tiao-Gan-Tang (QZTGT) prevents nonalcoholic steatohepatitis (NASH) by expression pattern correction;Journal of Ethnopharmacology;2023-12